Clinical trial
Randomized Study Evaluating the Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
NCT00273741 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study Evaluating the Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2007
- Completion date
- June 30, 2009
- Enrollment
- 39 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.